Anzeige
Meldung des Tages: Jetzt wird gebohrt: Kann dieser Kupfer-Nanocap zur Sommer-Story 2026 werden?

Sanofi

Aktie
WKN:  920657 ISIN:  FR0000120578 US-Symbol:  SNYNF Branche:  Pharmazeutika Land:  Frankreich
75,16 €
+0,16 €
+0,21%
14:58:17 Uhr
Depot/Watchlist
Marktkapitalisierung *
88,49 Mrd. €
Streubesitz
50,00%
KGV
12,97
Dividende
3,92 EUR
Dividendenrendite
5,02%
Nachhaltigkeits-Score
69 %
Index-Zuordnung
Euro Stoxx 50
Weiter aufwärts? Long handeln - Jetzt mit Hebel 6,02: MK3VTF
Werbung

Ad-hocs

09.06.25 - GlobeNewswire
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus ...
05.06.25 - GlobeNewswire
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
Sanofi Launches 2025 Global Employee Stock Purchase Plan
03.06.25 - GlobeNewswire
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
ASCO: new Sarclisa data support subcutaneous administration with on-body injector
03.06.25 - GlobeNewswire
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, ...
30.05.25 - GlobeNewswire
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe ...
29.05.25 - GlobeNewswire
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Beyfortus public health advantage bolstered by first real-​world comparison of infant vs maternal RSV immunization programs Late-​breaking data show infant respiratory syncytial ...
27.05.25 - GlobeNewswire
Press Release: Sanofi completes acquisition of DR-0201
Sanofi completes acquisition of DR-0201
22.05.25 - GlobeNewswire
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today ...

Newssuche

Videos

newspaper
09:20 Uhr -0,49%
Technical Trading: Zukauf Chance Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »